News

The updated warnings highlight a rare risk of heart inflammation in teen boys and young men, CBS News reported. The warning ...
The FDA is requiring COVID vaccine makers Pfizer and Moderna to update their warnings about the possible risk of myocarditis and pericarditis.
Cardiovascular issues are common, and now some experts term severe COVID an independent coronary artery disease risk factor ...
As Covid-19 cases begin to rise again in several parts of the world, concerns regarding vaccine side effects have re-emerged.
The Food and Drug Administration is requiring Pfizer and Moderna to expand warnings on the labels of their COVID-19 vaccines ...
Acute coronary syndrome (ACS) in patients with SARS-CoV-2 infection represents a critical intersection of viral-induced inflammation and cardiovascular pathology.
Top federal health officials actively took steps to “delay warning the public” for months in 2021 about the potential risks of heart-related complications from receiving mRNA COVID-19 vaccines ...
The FDA has approved the Novavax COVID-19 vaccine, called Nuvaxovid, mainly for adults 65 or older, but people ages 12 to 64 with medical conditions that increase their risk of serious illness from ...